Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell cycle is a highly regulated series of events comprising DNA replication, chromosome segregation, and cytokinesis that allows for fungal growth and reproduction (Berman, 2006). This process is coordinated by central regulatory proteins, primarily cyclin-dependent kinases (CDKs) like Cdc28/Cdk1, which associate with stage-specific cyclins to drive cells through G1, S, G2, and M phases (Enserink & Kolodner, 2010). As a therapeutic target, the fungal cell cycle offers opportunities for selective toxicity by exploiting structural differences in fungal-specific proteins or unique regulatory mechanisms, such as those involved in bud site selection or fungal-specific spindle pole body dynamics (Schuldiner et al., 2005). Clinically used drugs like griseofulvin target the fungal cell cycle by binding to tubulin and disrupting the mitotic spindle, while others like flucytosine interfere with DNA synthesis to induce S-phase arrest (Panda et al., 2005; Vermes et al., 2000). Although many core components are conserved across eukaryotes, the distinct requirements for fungal cytokinesis and the presence of unique fungal cyclins make this biological process a valuable, albeit complex, area for antifungal drug development (Hartwell, 1974; Rusche & Rine, 2010).
Inhibition of specific cell cycle components such as microtubules (disrupting the mitotic spindle), DNA polymerases (halting S-phase progression), or regulatory kinases (preventing phase transitions), resulting in cell cycle arrest and inhibition of fungal growth.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell cycle.